Health & Science
Tau-Targeting Alzheimer's Drug Shows Promise in Trial
Biogen's diranersen targeting tau protein shows cognitive benefits in Phase 2 Alzheimer's trial, offering a new pathway beyond amyloid.
—4 min read
Category
Health & Science
6 articles
Health & ScienceBiotechnology
China Approves World's First CAR-T Therapy for Solid Tumors
China's NMPA approved satri-cel, the world's first CAR-T therapy for solid tumors, targeting advanced gastric cancer at 990,000 yuan per infusion.
—5 min read
Health & Science
Genetic Test Spares Many Breast Cancer Patients from Chemo
A landmark trial shows the Prosigna genetic test can identify breast cancer patients who can safely skip chemotherapy and its harsh side effects
—4 min read
Health & ScienceTechnology
mRNA Vaccine Cuts Melanoma Recurrence Risk by 49% in Trial
A personalized mRNA cancer vaccine from Moderna and Merck reduced melanoma recurrence risk by 49% over five years, marking a major advance.
—4 min read
Health & Science
Eli Lilly's Retatrutide Yields 28% Weight Loss in Trial
Eli Lilly's retatrutide led to 28.3% weight loss in a Phase 3 trial, approaching bariatric surgery results. But high side effect rates raise questions.
—5 min read
Health & Science
How the APOE2 Gene Protects the Brain From Aging
A new study reveals how the APOE2 longevity gene protects neurons from aging and Alzheimer's by boosting DNA repair and resisting cellular senescence.
—4 min read